Clinical Focus on ART
Published on 30. December 2025
Book
Paperback/Softback
264 pages
978-93-7545-433-5 (ISBN)
More details
Language
English
Place of publication
New Delhi
India
Target group
Professional and scholarly
Product notice
Paperback (trade)
Dimensions
Height: 240 mm
Width: 168 mm
Thickness: 10 mm
Weight
459 gr
ISBN-13
978-93-7545-433-5 (9789375454335)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Persons
Narendra Malhotra MD FIAJAGO FICMU FICOG FICMCH FRCOG FICS FMAS FIAPM FICRM
Managing Director, Global Rainbow Health Care and MNMH (P) Ltd and Ujala Cygnus Rainbow Hospital, Agra, Uttar Pradesh, India
Jaideep Malhotra MD FICOG FICS FIUMB FICMCH FMAS FRCPI FRCOG FICRM FIAPM
Managing Director, ART Rainbow IVF Infertility, Agra, Uttar Pradesh, India
Neharika Malhotra MD (Gold Medalist) DRM (Germany) DMIS FICMCH FMAS FICOG ICOG Fellowship in Reproductive Medicine DGC
Consultant, Department of Obstetrics and Gynaecology, Ujala Cygnus Rainbow Hospital, Agra, Uttar Pradesh, India
Neha Priyadarshini MD FRM FICOG FICMCH
Medical Director, Department of IVF, Satvik IVF, Dhanbad, Jharkhand, India
Managing Director, Global Rainbow Health Care and MNMH (P) Ltd and Ujala Cygnus Rainbow Hospital, Agra, Uttar Pradesh, India
Jaideep Malhotra MD FICOG FICS FIUMB FICMCH FMAS FRCPI FRCOG FICRM FIAPM
Managing Director, ART Rainbow IVF Infertility, Agra, Uttar Pradesh, India
Neharika Malhotra MD (Gold Medalist) DRM (Germany) DMIS FICMCH FMAS FICOG ICOG Fellowship in Reproductive Medicine DGC
Consultant, Department of Obstetrics and Gynaecology, Ujala Cygnus Rainbow Hospital, Agra, Uttar Pradesh, India
Neha Priyadarshini MD FRM FICOG FICMCH
Medical Director, Department of IVF, Satvik IVF, Dhanbad, Jharkhand, India
Content
SECTION 1: Foundations and Epidemiology
1. History and Epidemiology of Infertility
2. Psychosocial Impact on Individuals and Couples
3. Environmental and Lifestyle Contributors to Infertility
SECTION 2: Diagnostic Workup
4. Comprehensive Clinical Evaluation and Basic Investigations
5. Advances in Semen Analysis and Sperm Deoxyribonucleic Acid (DNA) Fragmentation
6. Ovarian Reserve Assessment and Anti-MA1/4llerian Hormone
7. Imaging Innovations: Hysterosalpingography, Three-dimensional Ultrasound, and Sonohysterography
SECTION 3: Emerging Biological Insights
8. Unexplained Infertility: Folate Pathway Variants, Epigenetic Mechanisms, Immune Dysregulation
SECTION 4: Artificial Reproductive
9. Fertility Preservation Technologies
10. Embryo Selection: Artificial Intelligence-driven Multimodal Grading and Explainability
11. Non-invasive and Minimally Invasive Preimplantation Genetic Testing and Advances in Next-generation Sequencing
12. Ethical and Clinical Debates: Preimplantation Genetic Screening, Blastocyst Transfer, and BMI Limits
SECTION 5: Special Causes and Populations
13. Endometriosis-associated Infertility: Mechanisms and Clinical Pathways
14. Polycystic Ovary Syndrome and Anovulation
15. Age-related Ovarian Decline and Poor Ovarian Response
16. Male Infertility: Emerging Diagnostics and Microsurgical
17. Impact of Cancer Treatment on Fertility and Preservation Strategies
SECTION 6: Therapeutics and Adjuncts
18. Ovulation Induction Protocols and Assisted Reproductive Technology Medications
19. Role of Antioxidants and Supplements in Infertility
20. Growth Factors and Regenerative Medicine: Platelet-rich Plasma in Uterine and Ovarian Applications
21. Lifestyle Modifications and Stress Management for Infertility Patients
SECTION 7: Clinical Challenges and Controversies
22. Managing Unexplained and Idiopathic Infertility
23. In Vitro Fertilization in Low-resource Settings: Challenges, Innovations, and Global Lessons
SECTION 8: Support, Ethics, and Broader Outcomes
24. Counseling Strategies and Supporting Diverse Family Structures
25. Ethical, Religious, and Legal Considerations in Assisted Reproductive Technology
26. Long-term Health of ART: Conceived Children and Reproductive Outcomes
27. Endometriosis and Assisted Reproductive Technology
1. History and Epidemiology of Infertility
2. Psychosocial Impact on Individuals and Couples
3. Environmental and Lifestyle Contributors to Infertility
SECTION 2: Diagnostic Workup
4. Comprehensive Clinical Evaluation and Basic Investigations
5. Advances in Semen Analysis and Sperm Deoxyribonucleic Acid (DNA) Fragmentation
6. Ovarian Reserve Assessment and Anti-MA1/4llerian Hormone
7. Imaging Innovations: Hysterosalpingography, Three-dimensional Ultrasound, and Sonohysterography
SECTION 3: Emerging Biological Insights
8. Unexplained Infertility: Folate Pathway Variants, Epigenetic Mechanisms, Immune Dysregulation
SECTION 4: Artificial Reproductive
9. Fertility Preservation Technologies
10. Embryo Selection: Artificial Intelligence-driven Multimodal Grading and Explainability
11. Non-invasive and Minimally Invasive Preimplantation Genetic Testing and Advances in Next-generation Sequencing
12. Ethical and Clinical Debates: Preimplantation Genetic Screening, Blastocyst Transfer, and BMI Limits
SECTION 5: Special Causes and Populations
13. Endometriosis-associated Infertility: Mechanisms and Clinical Pathways
14. Polycystic Ovary Syndrome and Anovulation
15. Age-related Ovarian Decline and Poor Ovarian Response
16. Male Infertility: Emerging Diagnostics and Microsurgical
17. Impact of Cancer Treatment on Fertility and Preservation Strategies
SECTION 6: Therapeutics and Adjuncts
18. Ovulation Induction Protocols and Assisted Reproductive Technology Medications
19. Role of Antioxidants and Supplements in Infertility
20. Growth Factors and Regenerative Medicine: Platelet-rich Plasma in Uterine and Ovarian Applications
21. Lifestyle Modifications and Stress Management for Infertility Patients
SECTION 7: Clinical Challenges and Controversies
22. Managing Unexplained and Idiopathic Infertility
23. In Vitro Fertilization in Low-resource Settings: Challenges, Innovations, and Global Lessons
SECTION 8: Support, Ethics, and Broader Outcomes
24. Counseling Strategies and Supporting Diverse Family Structures
25. Ethical, Religious, and Legal Considerations in Assisted Reproductive Technology
26. Long-term Health of ART: Conceived Children and Reproductive Outcomes
27. Endometriosis and Assisted Reproductive Technology